Precision Biologics: How Monoclonal Antibody Therapeutics Are Targeting Iron Metabolism
The Hemojuvelin Monoclonal Antibody Market is experiencing significant growth as monoclonal antibody therapeutics continue to target iron metabolism and related disorders. According to market reports, the global Hemojuvelin Monoclonal Antibody Market was valued at USD 400 million in 2024 and is projected to reach USD 1,500 million by 2035, exhibiting an impressive CAGR of 13.4% during...
0 Yorumlar 0 hisse senetleri 96 Views 0 önizleme